National Bank of Canada
IBB icon

National Bank of Canada’s iShares Biotechnology ETF IBB Stock Holding History

National Bank of Canada’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Sell
2,029
-89
-4% -$15.3K ﹤0.01% 1512
2026
Q1 		$358K Sell
2,118
-226
-10% -$38.6K ﹤0.01% 1474
2025
Q4 		$396K Buy
2,344
+223
+11% +$36.2K ﹤0.01% 1419
2025
Q3 		$306K Sell
2,121
-860
-29% -$117K ﹤0.01% 1449
2025
Q2 		$377K Sell
2,981
-494
-14% -$60.6K ﹤0.01% 1468
2025
Q1 		$444K Sell
3,475
-369
-10% -$50K ﹤0.01% 1343
2024
Q4 		$508K Sell
3,844
-280
-7% -$39.4K ﹤0.01% 1423
2024
Q3 		$600K Buy
4,124
+229
+6% +$33.1K ﹤0.01% 1177
2024
Q2 		$533K Buy
3,895
+324
+9% +$43.3K ﹤0.01% 1163
2024
Q1 		$476K Buy
3,571
+184
+5% +$25.1K ﹤0.01% 1250
2023
Q4 		$467K Sell
3,387
-285
-8% -$34.8K ﹤0.01% 1284
2023
Q3 		$441K Sell
3,672
-1,153
-24% -$147K ﹤0.01% 1366
2023
Q2 		$612K Buy
4,825
+7
+0.1% +$909 ﹤0.01% 1257
2023
Q1 		$623K Sell
4,818
-674
-12% -$88.2K ﹤0.01% 1174
2022
Q4 		$721K Sell
5,492
-1,875
-25% -$242K ﹤0.01% 1174
2022
Q3 		$861K Sell
7,367
-3,146
-30% -$391K ﹤0.01% 1026
2022
Q2 		$1.24M Buy
10,513
+163
+2% +$19.3K 0.01% 947
2022
Q1 		$1.28M Buy
10,350
+509
+5% +$66.3K ﹤0.01% 1020
2021
Q4 		$1.5M Buy
+9,841
New +$1.52M 0.01% 913

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

National Bank of Canada's IBB Position: Q2 2026 in Review

National Bank of Canada reduced its iShares Biotechnology ETF (IBB) stake by 4.2% in Q2 2026, selling an estimated $15.3K and leaving 2,029 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

National Bank of Canada first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.5M in Q4 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • National Bank of Canada held 2,029 shares of iShares Biotechnology ETF worth $383K as of Q2 2026.
  • National Bank of Canada sold 89 iShares Biotechnology ETF shares in Q2 2026, an estimated $15.3K.
  • iShares Biotechnology ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #1512 holding.
  • National Bank of Canada first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's iShares Biotechnology ETF position peaked at $1.5M in Q4 2021.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.